International Journal of Pharmaceutics-X

Papers
(The H4-Index of International Journal of Pharmaceutics-X is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Phloretin-nanospanlastics for targeting the Akt/PI3K signaling pathways in dimethylhydrazine-induced colon cancer in mice116
Tailored ASD destabilization - Balancing shelf life stability and dissolution performance with hydroxypropyl cellulose42
Transferrin conjugated pH/NIR-responsive black phosphorus nanoplatform: A novel multimodal approach for breast cancer theranostics34
Tailored transethosomal systems for tadalafil transdermal delivery: Impact of Phosal and edge activators on skin permeation and cellular uptake34
Rationalized landscape on protein-based cancer nanomedicine: Recent progress and challenges32
Exploring high-throughput synchrotron X-Ray powder diffraction for the structural analysis of pharmaceuticals28
HSPiP and QbD oriented optimized nanocubosomes for ameliorated absorption of tolterodine tartrate: In vitro and in vivo evaluations26
Exploiting recent trends for the synthesis and surface functionalization of mesoporous silica nanoparticles towards biomedical applications24
Everolimus-encapsulation in Pluronic P123 self-assembled micelles as drug delivery systems for drug-coated balloons22
Continuous direct compression: Development of an empirical predictive model and challenges regarding PAT implementation19
Enhancing oocyte in vitro maturation and quality by melatonin/bilirubin cationic nanoparticles: A promising strategy for assisted reproduction techniques18
Modeling of physical-mechanical and microbiological properties of tablets made of complex fluidized bed granules containing living yeast cells using common mixing rules18
Exploring bioadhesion: insight on innovative strategies to investigate bioadhesive scaffolds17
Erratum regarding missing Conflict of Interest statements in previously published articles17
Polydopamine-activated celastrol carbon dots for synergistic chemotherapy-photothermal therapy of tumors17
Synergistic photodynamic and chemodynamic therapy using hypoxia-adaptive Ce6@Co nanoparticles for enhanced tumor suppression17
A novel nanomicelle based on Rebaudioside A: An oral nanoplatform with enhanced nephroprotective effect of myricetin17
0.18955588340759